Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon
- PMID: 3016718
- PMCID: PMC386375
- DOI: 10.1073/pnas.83.16.5764
Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon
Abstract
BALB/c embryonic fibroblasts productively transformed by Moloney sarcoma virus and cultivated for over 600 generations in the presence of mouse alpha/beta interferon reverted to an apparently normal phenotype and were unable to produce tumors in nude mice. Nevertheless, the presence of an integrated Moloney sarcoma virus genome in the nonmalignant Moloney sarcoma virus-transformed interferon-treated cell DNA could be shown by focus formation upon transfection and by hybridization with a v-mos probe. After digestion with various restriction endonucleases, similar hybridization patterns of v-mos sequences were obtained with DNAs from both reverted and transformed cells. However, additional integration sites and at least twice as many copies of the oncogene were found in the nonmalignant Moloney sarcoma virus-transformed interferon-treated cell DNA. Polyadenylylated RNA extracted from reverted and control cells contained two mos-specific transcripts. Interestingly, the nonmalignant Moloney sarcoma virus-transformed interferon-treated cells produced helper virus, but no detectable mos-containing virions, suggesting that a posttranscriptional block in the v-mos gene expression had occurred in these cells. It should be stressed that, after up to 100 additional passages, cells cultured in the absence of interferon maintained their nontumorigenic character in spite of the persistent transcription of the mos oncogene.
Similar articles
-
A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.Mol Carcinog. 1990;3(2):103-13. doi: 10.1002/mc.2940030208. Mol Carcinog. 1990. PMID: 2161237
-
Temperature-sensitive viral RNA expression in Moloney murine sarcoma virus ts110-infected cells.J Virol. 1985 Feb;53(2):616-23. doi: 10.1128/JVI.53.2.616-623.1985. J Virol. 1985. PMID: 2982039 Free PMC article.
-
Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.Proc Natl Acad Sci U S A. 1985 Jun;82(12):4198-201. doi: 10.1073/pnas.82.12.4198. Proc Natl Acad Sci U S A. 1985. PMID: 2987967 Free PMC article.
-
The ts110 Moloney mouse sarcoma virus system: gag-mos gene products and cellular transformation.J Gen Virol. 1985 Sep;66 ( Pt 9):1845-53. doi: 10.1099/0022-1317-66-9-1845. J Gen Virol. 1985. PMID: 2993477 Review. No abstract available.
-
Interferon and reversion of the transformed phenotype.Surv Immunol Res. 1982;1(4):316-22. doi: 10.1007/BF02918542. Surv Immunol Res. 1982. PMID: 6195717 Review. No abstract available.
Cited by
-
Short-term treatment with gamma interferon induces stable reversion of ras-transformed mouse fibroblasts.J Virol. 1991 Nov;65(11):6307-11. doi: 10.1128/JVI.65.11.6307-6311.1991. J Virol. 1991. PMID: 1717721 Free PMC article.
-
Roles of interferon produced in physiological conditions. A speculative review.Immunology. 1988 May;64(1):1-9. Immunology. 1988. PMID: 2454881 Free PMC article. Review. No abstract available.
-
Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression.J Virol. 1987 Aug;61(8):2567-72. doi: 10.1128/JVI.61.8.2567-2572.1987. J Virol. 1987. PMID: 3037117 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources